Cubist Pharmaceuticals (NASDAQ:CBST)

Bull and Bear

Top Analyst Upgrades and Downgrades: AmEx, Apache, Cliffs, Denbury, JetBlue, Synchrony and More

Stocks were weak on Thursday after negative news overseas. Still, investors keep proving that they are willing to buy discounted or overlooked stocks. 24/7 Wall St. reviews dozens of analyst ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: DuPont, GE, King, Microsoft, Xilinx, McDonald’s and More

Stocks were indicated slightly higher Wednesday morning, after earnings and on hopes that geopolitical risks would abate. Investors still want upside, and they are looking for stocks and sectors where ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
biotech

As Antibiotics Stop Working, Five Biotechs Seek Cures

One of the main concerns physicians have agreed upon in recent years has been the overuse of antibiotics by some health care professionals. Their overuse in some cases has led ...
Read Full Story »
biotech

Companies Betting on the Next 10 Blockbuster Drugs

The biotech sector has seen its valuations hit hard in many cases in 2014, but many investors remain excited about the future wave of big biotech drugs -- and big ...
Read Full Story »
462542665

Jefferies Stocks to Buy That Could Jump From an Earnings Surprise

The extreme market volatility of the past few weeks has left some investors very nervous. Ongoing selling of technology (Internet) and biotech shares spilled over into the broad market during ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »
biotech

Jefferies Top Biotech Stocks to Buy

The world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Anadarko, Cubist, K12, EOG and More

Earnings season has just started, and investors and traders alike are having to face a government shutdown and a debt ceiling debate painfully developing each day. So which companies and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, Cubist, Whole Foods and More

Stocks have seen five days of selling, and investors are deciding which stocks are bargains and which ones will have more downside. 24/7 Wall St. reviews dozens of Wall Street ...
Read Full Story »
biotech

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report ...
Read Full Story »
biotech

PropThink Biotech Stocks With Big Upside Potential

The world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday’s comments by Fed Chairman Ben Bernanke that the Fed could slow its bond purchases in ...
Read Full Story »
Bull and Bear

Top 10 Analyst Upgrades and Downgrades: Cubist, Marvell, PG and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
biotech

PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More

The world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the ...
Read Full Story »